KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Castle Biosciences (CSTL) Shares Outstanding (Weighted Average): 2018-2025

Historic Shares Outstanding (Weighted Average) for Castle Biosciences (CSTL) over the last 7 years, with Sep 2025 value amounting to $29.0 million.

  • Castle Biosciences' Shares Outstanding (Weighted Average) rose 4.58% to $29.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $29.0 million, marking a year-over-year increase of 4.58%. This contributed to the annual value of $28.0 million for FY2024, which is 4.08% up from last year.
  • According to the latest figures from Q3 2025, Castle Biosciences' Shares Outstanding (Weighted Average) is $29.0 million, which was up 0.47% from $28.9 million recorded in Q2 2025.
  • Castle Biosciences' 5-year Shares Outstanding (Weighted Average) high stood at $29.0 million for Q3 2025, and its period low was $25.0 million during Q1 2021.
  • Over the past 3 years, Castle Biosciences' median Shares Outstanding (Weighted Average) value was $27.6 million (recorded in 2024), while the average stood at $27.7 million.
  • Data for Castle Biosciences' Shares Outstanding (Weighted Average) shows a peak YoY soared of 45.51% (in 2021) over the last 5 years.
  • Over the past 5 years, Castle Biosciences' Shares Outstanding (Weighted Average) (Quarterly) stood at $25.3 million in 2021, then grew by 4.16% to $26.4 million in 2022, then climbed by 2.12% to $26.9 million in 2023, then climbed by 4.08% to $28.0 million in 2024, then grew by 4.58% to $29.0 million in 2025.
  • Its Shares Outstanding (Weighted Average) was $29.0 million in Q3 2025, compared to $28.9 million in Q2 2025 and $28.5 million in Q1 2025.